• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Recognized Consensus Standards

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search Back To Search Results
Recognition List Number: 030 Publication Date: 01/15/2013 

Part B: SUPPLEMENTARY INFORMATION

Recognition Number 14-296: AAMI / ANSI / ISO 11138-1:2006/(R)2010, Sterilization of health care products - Biological indicators - Part 1: General requirements. (Sterility)

Date of Standard: 2006. 
Addresses of Standards Organizations:
  Association for the Advancement of Medical Instrumentation (AAMI)
  4301 North Fairfax Drive
  Suite 301
  Arlington, VA 22203
 
  American National Standards Institute (ANSI)
  25 West 43rd Street
  4th Floor
  New York, NY 10036
 
  International Organization for Standardization (ISO)*
  1, Rue de Varembe
  Case Postale 56
  CH 1211 Geneva 20, 0
  SWITZERLAND
CDRH Offices and Divisions Associated with Recognized Standards:
(1)OFFICE OF DEVICE EVALUATION (ODE)
(2)OFFICE OF COMPLIANCE (OC)
DIVISION OF ENFORCEMENT A (DOEA)
Devices Affected:
Biological indicators intended for use by health care facilities for monitoring sterilization processes
Processes Affected:
510(k), PMA, PDP, IDE, HDE, Design Control Input, Quality System Regulation
Type of Standard:
 Vertical, International
Extent of Recognition:
Complete standard and any annexes except for sections referencing ISO 13485:2003. FDA requires medical device manufacturers to comply with the Code of Federal Regulations (CFR), 21 CFR Part 820 Quality System Regulation and therefore does not require compliance with ISO 13485 for the establishment of a Quality Management System.
Related CFR Citations and Product Codes:
Regulation
Number
Device Name Device
Class
Product
Code
§880.2800 Indicator, Biological Sterilization Process Class 2 FRC
 
Relevant Guidance:
USP 35-NF30:2012 Biological Indicators for Sterilization

USP 35-NF30:2012 Biological Indicators - Resistance Performance Tests

Guidance for Industry and FDA Staff; Biological Indicator (BI) Premarket Notification [510(k)] Submissions, October 4, 2007
FDA Technical Contacts:
  Cesar Perez, Ph.D.
  FDA/CDRH/OC
  10903 New Hampshire Avenue Building 66, Room 1561
  Silver Spring MD 20993
  301/796-5476
  Email: cesar.perez@fda.hhs.gov
  Geetha C. Jayan, M.V.Sc, Ph.D
  FDA/CDRH/OCD
  10903 New Hampshire Avenue Building 66, Room 5400
  Silver Spring MD 20993
  301/796-6300
  Email: geetha.jayan@fda.hhs.gov
* In the United States, copies of this standard can be obtained from:
  American National Standards Institute (ANSI)*
  25 West 43rd Street
  4th Floor
  New York, NY 10036
-
-